A Self-Adhesive Ginsenoside Rk3/Metformin-Loaded Hydrogel Microneedle for Management of Systemic Sclerosis

Microcirculation damage, dermal thickening, and difficulty in the spatiotemporal coordination of key platelet factor 4 (CXCL4) and transforming growth factor-β (TGF-β) contribute to the lack of effective treatments for systemic sclerosis (scleroderma, SSc). To address these challenges, we proposed a...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuanyuan Wang, Caiyun Zhong, Kexin Wang, Shihong Shen, Daidi Fan
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Gels
Subjects:
Online Access:https://www.mdpi.com/2310-2861/11/6/384
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839653938119311360
author Yuanyuan Wang
Caiyun Zhong
Kexin Wang
Shihong Shen
Daidi Fan
author_facet Yuanyuan Wang
Caiyun Zhong
Kexin Wang
Shihong Shen
Daidi Fan
author_sort Yuanyuan Wang
collection DOAJ
description Microcirculation damage, dermal thickening, and difficulty in the spatiotemporal coordination of key platelet factor 4 (CXCL4) and transforming growth factor-β (TGF-β) contribute to the lack of effective treatments for systemic sclerosis (scleroderma, SSc). To address these challenges, we proposed a novel synergistic drug combination of ginsenoside Rk3 (CXCL4 regulator) and metformin (Met, TGF-β regulator) based on molecular docking and developed an ultra-long release, dual-target regulation hydrogel microneedle system (Rk3/Met URS MN). The rapidly dissolving tips of this hydrogel microneedle consisted of polyvinyl alcohol and polyvinylpyrrolidone, and were loaded with polydopamine-coated, coordination-induced self-assembled Rk3/Met nanomedicines. These micro-tips could spatiotemporally synchronize transdermal delivery of the hydrophobic Rk3 and hydrophilic Met, providing ultra-long release for up to 10 days with a single administration. The recombinant collagen CF-1552/oxidized pullulan-based (CAOP) hydrogel backing exhibited skin self-adhesiveness and excellent mechanical properties and could perform localized moisture retention and free radical scavenging at the lesion site. In vitro and in vivo efficacy studies, along with bioinformatics analysis of RNA sequencing, demonstrated that the Rk3/Met URS MN achieved immune modulation, anti-inflammatory effects, angiogenesis promotion, and antifibrosis in SSc through synergistic CXCL4/TGF-β dual-target regulation. Notably, on the 10th day, the dermal thickness decreased from 248.97 ± 21.3 μm to 152.7 ± 18.1 μm, with no significant difference from the normal group, indicating its significant potential in clinical applications in SSc.
format Article
id doaj-art-f59f78c9c9e04c68aa2b039f00b2e5db
institution Matheson Library
issn 2310-2861
language English
publishDate 2025-05-01
publisher MDPI AG
record_format Article
series Gels
spelling doaj-art-f59f78c9c9e04c68aa2b039f00b2e5db2025-06-25T13:53:36ZengMDPI AGGels2310-28612025-05-0111638410.3390/gels11060384A Self-Adhesive Ginsenoside Rk3/Metformin-Loaded Hydrogel Microneedle for Management of Systemic SclerosisYuanyuan Wang0Caiyun Zhong1Kexin Wang2Shihong Shen3Daidi Fan4Engineering Research Center of Western Resource Innovation Medicine Green Manufacturing, Ministry of Education, School of Chemical Engineering, Northwest University, Xi’an 710127, ChinaEngineering Research Center of Western Resource Innovation Medicine Green Manufacturing, Ministry of Education, School of Chemical Engineering, Northwest University, Xi’an 710127, ChinaEngineering Research Center of Western Resource Innovation Medicine Green Manufacturing, Ministry of Education, School of Chemical Engineering, Northwest University, Xi’an 710127, ChinaEngineering Research Center of Western Resource Innovation Medicine Green Manufacturing, Ministry of Education, School of Chemical Engineering, Northwest University, Xi’an 710127, ChinaEngineering Research Center of Western Resource Innovation Medicine Green Manufacturing, Ministry of Education, School of Chemical Engineering, Northwest University, Xi’an 710127, ChinaMicrocirculation damage, dermal thickening, and difficulty in the spatiotemporal coordination of key platelet factor 4 (CXCL4) and transforming growth factor-β (TGF-β) contribute to the lack of effective treatments for systemic sclerosis (scleroderma, SSc). To address these challenges, we proposed a novel synergistic drug combination of ginsenoside Rk3 (CXCL4 regulator) and metformin (Met, TGF-β regulator) based on molecular docking and developed an ultra-long release, dual-target regulation hydrogel microneedle system (Rk3/Met URS MN). The rapidly dissolving tips of this hydrogel microneedle consisted of polyvinyl alcohol and polyvinylpyrrolidone, and were loaded with polydopamine-coated, coordination-induced self-assembled Rk3/Met nanomedicines. These micro-tips could spatiotemporally synchronize transdermal delivery of the hydrophobic Rk3 and hydrophilic Met, providing ultra-long release for up to 10 days with a single administration. The recombinant collagen CF-1552/oxidized pullulan-based (CAOP) hydrogel backing exhibited skin self-adhesiveness and excellent mechanical properties and could perform localized moisture retention and free radical scavenging at the lesion site. In vitro and in vivo efficacy studies, along with bioinformatics analysis of RNA sequencing, demonstrated that the Rk3/Met URS MN achieved immune modulation, anti-inflammatory effects, angiogenesis promotion, and antifibrosis in SSc through synergistic CXCL4/TGF-β dual-target regulation. Notably, on the 10th day, the dermal thickness decreased from 248.97 ± 21.3 μm to 152.7 ± 18.1 μm, with no significant difference from the normal group, indicating its significant potential in clinical applications in SSc.https://www.mdpi.com/2310-2861/11/6/384systemic sclerosishydrogel microneedleCXCL4/TGF-βultra-long releasereverse skin phenotype
spellingShingle Yuanyuan Wang
Caiyun Zhong
Kexin Wang
Shihong Shen
Daidi Fan
A Self-Adhesive Ginsenoside Rk3/Metformin-Loaded Hydrogel Microneedle for Management of Systemic Sclerosis
Gels
systemic sclerosis
hydrogel microneedle
CXCL4/TGF-β
ultra-long release
reverse skin phenotype
title A Self-Adhesive Ginsenoside Rk3/Metformin-Loaded Hydrogel Microneedle for Management of Systemic Sclerosis
title_full A Self-Adhesive Ginsenoside Rk3/Metformin-Loaded Hydrogel Microneedle for Management of Systemic Sclerosis
title_fullStr A Self-Adhesive Ginsenoside Rk3/Metformin-Loaded Hydrogel Microneedle for Management of Systemic Sclerosis
title_full_unstemmed A Self-Adhesive Ginsenoside Rk3/Metformin-Loaded Hydrogel Microneedle for Management of Systemic Sclerosis
title_short A Self-Adhesive Ginsenoside Rk3/Metformin-Loaded Hydrogel Microneedle for Management of Systemic Sclerosis
title_sort self adhesive ginsenoside rk3 metformin loaded hydrogel microneedle for management of systemic sclerosis
topic systemic sclerosis
hydrogel microneedle
CXCL4/TGF-β
ultra-long release
reverse skin phenotype
url https://www.mdpi.com/2310-2861/11/6/384
work_keys_str_mv AT yuanyuanwang aselfadhesiveginsenosiderk3metforminloadedhydrogelmicroneedleformanagementofsystemicsclerosis
AT caiyunzhong aselfadhesiveginsenosiderk3metforminloadedhydrogelmicroneedleformanagementofsystemicsclerosis
AT kexinwang aselfadhesiveginsenosiderk3metforminloadedhydrogelmicroneedleformanagementofsystemicsclerosis
AT shihongshen aselfadhesiveginsenosiderk3metforminloadedhydrogelmicroneedleformanagementofsystemicsclerosis
AT daidifan aselfadhesiveginsenosiderk3metforminloadedhydrogelmicroneedleformanagementofsystemicsclerosis
AT yuanyuanwang selfadhesiveginsenosiderk3metforminloadedhydrogelmicroneedleformanagementofsystemicsclerosis
AT caiyunzhong selfadhesiveginsenosiderk3metforminloadedhydrogelmicroneedleformanagementofsystemicsclerosis
AT kexinwang selfadhesiveginsenosiderk3metforminloadedhydrogelmicroneedleformanagementofsystemicsclerosis
AT shihongshen selfadhesiveginsenosiderk3metforminloadedhydrogelmicroneedleformanagementofsystemicsclerosis
AT daidifan selfadhesiveginsenosiderk3metforminloadedhydrogelmicroneedleformanagementofsystemicsclerosis